Polypill cuts cardiovascular event risk in seniors with recent MI
Aug 30, 2022
A polypill comprising aspirin, ramipril and atorvastatin is effective for secondary prevention of cardiovascular disease in older adults.
Overall cardiovascular health score less than optimal for U.S. adults
Jun 29, 2022
Significant differences in mean overall CVH scores were based on Life’s Essential 8 by sex, age and racial/ethnic group.
Approach for assessing cardiovascular health enhanced
Jun 29, 2022
Life’s Essential 8 updates many of the metrics from Life’s Simple 7 and adds new metric for sleep duration.
USPSTF: Do not start low-dose aspirin to prevent CVD in 60+
Apr 26, 2022
For those aged 40 to 59 years, the decision to initiate low-dose aspirin for primary prevention of CVD should be individualized.
Social isolation, loneliness up risk of new CVD in older women
Feb 03, 2022
The findings were independent of each other, with an even stronger effect seen for women with high levels of social isolation and loneliness.
Heart surgery patients may not need opioids at home
Dec 27, 2021
Older age, longer length of hospital stay and undergoing surgery during the past three months of the study were independent predictors of discharge without an opioid prescription.
Sex differences examined for mechanism of migraine-stroke link
Dec 08, 2021
Sex differences in stroke pathophysiology in patients with migraine seem unrelated to the prevalence of conventional cardiovascular risk factors.
USPSTF advises against starting aspirin in ≥60s to prevent CVD
Oct 12, 2021
The U.S. Preventive Services Task Force (USPSTF) recommends against initiating use of aspirin for the primary prevention of cardiovascular disease (CVD) for adults aged 60 years or older.
Individual a-fib episodes tied to recent alcohol intake
Aug 31, 2021
Individual atrial fibrillation (AF) episodes are associated with increased odds of recent alcohol consumption, according to a study published online Aug. 31 in the Annals of Internal Medicine.
More than one in four adults with cardiovascular disease currently smoke
Jun 11, 2021
From wave 1 to 4 of PATH, a <5% decrease was seen in cigarette use and a 0.5% increase was found in e-cigarette use.